Brief: Cytotools announces positive results in interim evaluation of European ulcer cruris study
June 29 (Reuters) - Cytotools AG T5OG.DE :
* Announces positive results in the interim evaluation of
European ulcer cruris study
* Continuation of the study as a phase III pivotal study
with 260 patients
Source text for Eikon: ID:nEQ3ltL2ra
Further company coverage: T5OG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)